期刊文献+

苓芍枣仁配方颗粒联合酒石酸托特罗定治疗女性膀胱过度活动伴性功能障碍临床观察 被引量:6

Clinical observation of Lingshao Zaoren Formula Granules combined with Tolterodine Tartrate for treatment of female patients with overactive bladder and sexual dysfunction
下载PDF
导出
摘要 目的:初步评价苓芍枣仁配方颗粒联合酒石酸托特罗定治疗青年女性膀胱过度活动症伴性功能障碍患者的临床疗效。方法:选择2017年4月至2017年11月中国中医科学院西苑医院泌尿外科门诊治疗的符合膀胱过度活动症诊断(膀胱过度活动症状评分问卷(OABSS)总得分≥3分,尿急症状得分≥2分。)年龄范围26岁~40岁的女性、有性生活史、女性性功能指数(FSFI)<25分、病程≥3个月例的患者10例。给予酒石酸托特罗定缓释片,每日一次,每次1片。同时配合口服苓芍枣仁配方颗粒。每天2次,每次1袋,连续治疗4周。比较10例患者治疗前后的OABSS评分、女性性功能指数(FSFI)评分。结果:治疗4周后10例患者的OABSS评分总分、尿急评分、尿失禁评分、FSFI评分总分,和治疗前相比较,差异具有统计学意义(P <0. 001)。其中FSFI评分中的性高潮评分和治疗前相比较,差异无统计学意义(P=0. 03)。性欲评分、性兴奋评分、阴道润滑评分、性交疼痛评分、性满意度评分和治疗前相比较,均有显著升高,差异具有统计学意义(P <0. 05)。结论:苓芍枣仁配方颗粒联合酒石酸托特罗定缓释片不仅可以缓解患者的尿频、尿急症状,也具有对患者的性功能障碍存在治疗作用。 Objective:To preliminarily evaluate the clinical curative effect of the Lingshao Zaoren Formula Granules combined with Tolterodine Tartrate for the treatment female patients with overactive bladder and sexual dysfunction.Methods:10 female patients diagnosed with bladder hyperactive disorder[Overactive Bladder Symptom Scores(OABSS)a total score of≥3,urgency symptoms score≥2]at Department of Urology in the Xiyuan Hospital of China Academy of Chinese Medical Sciences from April 2017 to November 2017 was chosen.The patients were all aged between 26-40 years old,with sexual life history,female sexual function index(FSFI)<25 and disease course>3months.All the 10 patients were given Tolterodine Tartrate,once a day,a tablet each time combined with Lingshao Zaoren Formula Granules,twice a day,a bag at a time for continuous treatment of 4 weeks.The OABSS scores and FSFI scores of patients before and after treatment were compared.Results:The total OABSS score,urgency score,urinary incontinence score and FSFI score of the10 patients after 4 weeks of treatment were significantly different from those before treatment,with statistically significant difference(P<0.001).There was no statistically significant difference in orgasm score between before and after treatment(P=0.03).Sexual desire score,sexual excitement score,vaginal lubrication score,intercourse pain score and sexual satisfaction score were significantly increased after treatment,with statistically significant difference(P<0.05).Conclusions:Lingshao Zaoren Formula Granules combined with Tolterodine Tartrate can not only alleviate patient′s symptoms of urinary frequency and urgency,but also has therapeutic effect for sexual dysfunction.
作者 沈建武 罗然 李奇 郑卫军 秦朋旭 李芋锦 柯刘盼 高瞻 SHEN ianwu;LUO Ran;LI Qi;ZHENG Weijun;QIN Pengxu;LI Yujin;KE Liupan;GAO Zhan(Department of Urology,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing 100091,China;Department of Infertility,Xiyuan Hospital of China Academy of Chinese Medical Sciences,Beijing 100091,China;College of Basic Medicine,Zhejiang Chinese Medical University,Hangzhou 310053,Zhejiang,China)
出处 《中国性科学》 2018年第11期103-105,共3页 Chinese Journal of Human Sexuality
基金 中央级公益性科研院所基本科研业务费专项资金资助(ZZ11-067) 北京市科学技术委员会资助项目(Z181100001718046) 中国中医科学院西苑医院育才人才培养计划(2014)
关键词 苓芍枣仁配方颗粒 膀胱过度活动症 膀胱过度活动症状评分问卷 女性性功能指数 Lingshao Zaoren Formula Granules Overactive bladder Overactive Bladder Symptom Scores(OABSS) Female sexual function index(FSFI)
  • 相关文献

参考文献6

二级参考文献50

  • 1杨尚琪,来永庆,陈月英,池泽湃,任瑞,王亚东,魏灿,倪梁朝,关志忱.膀胱过度活动症症状评分表评估膀胱过度活动症的临床研究[J].中华临床医师杂志(电子版),2012,6(16):4675-4678. 被引量:24
  • 2田贞姬,殷秀荣,辛钟成,高冰.中国中青年女性性功能调查[J].中国男科学杂志,2006,20(9):25-28. 被引量:9
  • 3Signorello LB, Harlow BL, Chekos AK, et al. Postpartum sexual functioning and its relationship to perineal trauma: A retrospective cohort study of primiparous women. Am J Obstet Gynecol, 2001, 184(5): 881-888.
  • 4Leiblum SR, Seehuus M. FSFI scores of women with persistent genital arousal disorder compared with published scores of women with female sexual arousal disorder and healthy controls. J Sex Med, 2009, 6(2) : 469-473.
  • 5Hatzimouratidis K, Hatzichristou D. Sexual dysfunctions: Classifications and definitions. J Sex Med, 2007, 4( 1 ) : 241-250.
  • 6Burri AV, Cherkas LM, Spector TD. The genetics and epidemiology of female sexual dysfunction : A review. J Sex Med, 2009,6(3) : 646-657.
  • 7Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI) : A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther, 2000, 26(2) : 191-208.
  • 8Song SH, Jeon H, Kim SW, et al. The prevalence and risk factors of female sexual dysfunction in young korean women : An intemet-based survey. J Sex Med, 2008, 5(7) : 1694-1701.
  • 9Asian E, Beji NK, Gungor I, et al. Prevalence and risk factors for low sexual function in women: A study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med, 2008, 5(9) : 2044-2052.
  • 10Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol, 2006, 175 ( 2 ) : 654- 658.

共引文献150

同被引文献63

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部